Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Friedman, Jeffrey
  • Rebel, V. I.
  • Derby, R.
  • Bell, K.
  • Huang, T. T.
  • Kuypers, F. A.
  • Epstein, C. J.
  • Burakoff, S. J.

publication date

  • April 2001

journal

  • Journal of Experimental Medicine  Journal

abstract

  • Manganese superoxide dismutase 2 (SOD2) is a critical component of the mitochondrial pathway for detoxification of O2(-), and targeted disruption of this locus leads to embryonic or neonatal lethality in mice. To follow the effects of SOD2 deficiency in cells over a longer time course, we created hematopoietic chimeras in which all blood cells are derived from fetal liver stem cells of Sod2 knockout, heterozygous, or wild-type littermates. Stem cells of each genotype efficiently rescued hematopoiesis and allowed long-term survival of lethally irradiated host animals. Peripheral blood analysis of leukocyte populations revealed no differences in reconstitution kinetics of T cells, B cells, or myeloid cells when comparing Sod2(+/+), Sod2(-/-), and Sod2(+/-) fetal liver recipients. However, animals receiving Sod2(-/-) cells were persistently anemic, with findings suggestive of a hemolytic process. Loss of SOD2 in erythroid progenitor cells results in enhanced protein oxidative damage, altered membrane deformation, and reduced survival of red cells. Treatment of anemic animals with Euk-8, a catalytic antioxidant with both SOD and catalase activities, significantly corrected this oxidative stress-induced condition. Such therapy may prove useful in treatment of human disorders such as sideroblastic anemia, which SOD2 deficiency most closely resembles.

subject areas

  • Anemia, Hemolytic
  • Animals
  • Antioxidants
  • B-Lymphocytes
  • Bone Marrow Cells
  • Cell Transplantation
  • Ethylenediamines
  • Fetal Tissue Transplantation
  • Free Radical Scavengers
  • Genotype
  • Heterozygote
  • Isoenzymes
  • Liver
  • Mice
  • Mice, Knockout
  • Mitochondria
  • Organometallic Compounds
  • Polymerase Chain Reaction
  • Spleen
  • Superoxide Dismutase
  • T-Lymphocytes
  • Thymus Gland
  • Transplantation Chimera
scroll to property group menus

Research

keywords

  • SOD2
  • antioxidant
  • oxidative stress
  • stem cells
  • transplantation (fetal liver)
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0022-1007

Digital Object Identifier (DOI)

  • 10.1084/jem.193.8.925

PubMed ID

  • 11304553
scroll to property group menus

Additional Document Info

start page

  • 925

end page

  • 934

volume

  • 193

issue

  • 8

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support